Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism

James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525
James M. Rae
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadia V. Soukhova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Flockhart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeruesenay Desta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 30 no. 5 525-530
DOI 
https://doi.org/10.1124/dmd.30.5.525
PubMed 
11950782

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 29, 2001
  • Accepted January 25, 2002
  • Published online May 1, 2002.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. James M. Rae1,
  2. Nadia V. Soukhova,
  3. David A. Flockhart2 and
  4. Zeruesenay Desta2
  1. Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Georgetown University Medical Center, Washington, DC
  1. James Michael Rae, University of Michigan Medical Center, Department of Internal Medicine, Med Sci 1, Room 5312, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0612. E-mail address: jimmyrae{at}umich.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 20172187
Sep 20172259
Oct 20170125
Nov 20171245
Dec 20171155
Jan 20182165
Feb 20181125
Mar 20184124
Apr 20181195
May 20180293
Jun 20180385
Jul 20181174
Aug 20186132
Sep 20182142
Oct 20181156
Nov 20183175
Dec 20181696
Jan 20191821
Feb 20191521
Mar 20191141
Apr 20192350
May 20192511
Jun 2019512
Jul 20191021
Aug 20191553
Oct 20193100
Nov 20192401
Dec 20191282
Jan 20201720
Feb 2020751
Mar 20201840
May 20202121
Jun 20202911
Jul 20201410
Aug 2020711
Sep 20201761
Oct 20202010
Nov 20201531
Dec 20202182
Jan 202119182
Feb 20219171
Mar 20212233
Apr 20212350
May 20211192
Jun 202128131
Jul 20211740
Aug 202111131
Sep 202113106
Oct 20211540
Nov 20212740
Dec 20212330
Jan 20222910
Feb 2022862
Mar 20221730
Apr 2022861
May 20222241
Jun 20221210
Jul 20221610
Aug 20221441
Sep 20221441
Oct 202218141
Nov 20222200
Dec 20221532
Jan 20233662

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 30 (5)
Drug Metabolism and Disposition
Vol. 30, Issue 5
1 May 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism

James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
Drug Metabolism and Disposition May 1, 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism

James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
Drug Metabolism and Disposition May 1, 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Series-Compartment Models of Hepatic Elimination
  • Warfarin PBPK Model with TMDD Mechanism
  • Identification of payload-containing catabolites of ADCs
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics